Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Single cell expression analysis reveals anatomical and cell cycle-dependent transcriptional shifts during heart development.

Li G, Tian L, Goodyer W, Kort EJ, Buikema JW, Xu A, Wu JC, Jovinge S, Wu SM.

Development. 2019 Jun 14;146(12). pii: dev173476. doi: 10.1242/dev.173476.

PMID:
31142541
2.

Anti-tumor effect of sulfasalazine in neuroblastoma.

Mooney MR, Geerts D, Kort EJ, Bachmann AS.

Biochem Pharmacol. 2019 Apr;162:237-249. doi: 10.1016/j.bcp.2019.01.007. Epub 2019 Jan 9.

PMID:
30639262
3.

Streamlined analysis of LINCS L1000 data with the slinky package for R.

Kort EJ, Jovinge S.

Bioinformatics. 2019 Jan 10. doi: 10.1093/bioinformatics/btz002. [Epub ahead of print]

PMID:
30629124
4.

Patent Ductus Arteriosus in the Preterm Infant: An Update on Morbidity and Mortality.

Kort EJ.

Curr Pediatr Rev. 2016;12(2):98-105. Review.

PMID:
27197950
5.

Circulating Progenitor Cells and Childhood Cardiovascular Disease.

Kort EJ, Croskey L, Scibienski T, Rajasekaran S, Jovinge S.

Pediatr Cardiol. 2016 Feb;37(2):225-31. doi: 10.1007/s00246-015-1300-8. Epub 2015 Nov 11. Review.

PMID:
26554720
6.

Dual KS: Defining Gene Sets with Tissue Set Enrichment Analysis.

Yang Y, Kort EJ, Ebrahimi N, Zhang Z, Teh BT.

Cancer Inform. 2010 Jan 21;9:1-9.

7.

Microarray gene expression profiling using core biopsies of renal neoplasia.

Rogers CG, Ditlev JA, Tan MH, Sugimura J, Qian CN, Cooper J, Lane B, Jewett MA, Kahnoski RJ, Kort EJ, Teh BT.

Am J Transl Res. 2009 Jan 1;1(1):55-61.

8.

The tumor suppressor parafibromin is required for posttranscriptional processing of histone mRNA.

Farber LJ, Kort EJ, Wang P, Chen J, Teh BT.

Mol Carcinog. 2010 Mar;49(3):215-23. doi: 10.1002/mc.20591.

PMID:
19908240
9.

Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models.

Qian CN, Furge KA, Knol J, Huang D, Chen J, Dykema KJ, Kort EJ, Massie A, Khoo SK, Vanden Beldt K, Resau JH, Anema J, Kahnoski RJ, Morreau H, Camparo P, Comperat E, Sibony M, Denoux Y, Molinie V, Vieillefond A, Eng C, Williams BO, Teh BT.

Cancer Res. 2009 Nov 1;69(21):8256-64. doi: 10.1158/0008-5472.CAN-09-1689. Epub 2009 Oct 20.

10.

The decline in U.S. cancer mortality in people born since 1925.

Kort EJ, Paneth N, Vande Woude GF.

Cancer Res. 2009 Aug 15;69(16):6500-5. doi: 10.1158/0008-5472.CAN-09-0357.

11.

Trends in esophageal cancer and body mass index by race and gender in the state of Michigan.

Kort EJ, Sevensma E, Fitzgerald TL.

BMC Gastroenterol. 2009 Jun 23;9:47. doi: 10.1186/1471-230X-9-47.

12.

MicroRNA profiling of human kidney cancer subtypes.

Petillo D, Kort EJ, Anema J, Furge KA, Yang XJ, Teh BT.

Int J Oncol. 2009 Jul;35(1):109-14.

PMID:
19513557
13.

Review paper: Gene expression profiling in veterinary and human medicine: overview of applications and proposed quality control practices.

Kort EJ, Norton P, Haak P, Berghuis B, Ramirez S, Resau J.

Vet Pathol. 2009 Jul;46(4):598-603. doi: 10.1354/vp.08-VP-0276-R-REV. Epub 2009 Mar 9. Review.

PMID:
19276055
14.

Archived unfrozen neonatal blood spots are amenable to quantitative gene expression analysis.

Haak PT, Busik JV, Kort EJ, Tikhonenko M, Paneth N, Resau JH.

Neonatology. 2009;95(3):210-6. doi: 10.1159/000155652. Epub 2008 Sep 18.

15.

Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response.

Koeman JM, Russell RC, Tan MH, Petillo D, Westphal M, Koelzer K, Metcalf JL, Zhang Z, Matsuda D, Dykema KJ, Houseman HL, Kort EJ, Furge LL, Kahnoski RJ, Richard S, Vieillefond A, Swiatek PJ, Teh BT, Ohh M, Furge KA.

PLoS Genet. 2008 Sep 5;4(9):e1000176. doi: 10.1371/journal.pgen.1000176. Erratum in: PLoS Genet. 2008 Jul;4(7). doi: 10.1371/annotation/7f57058f-cc02-45a6-bfab-a835619e3916.

16.

Changing incidence of pancreatic neoplasms: a 16-year review of statewide tumor registry.

Fitzgerald TL, Hickner ZJ, Schmitz M, Kort EJ.

Pancreas. 2008 Aug;37(2):134-8. doi: 10.1097/MPA.0b013e318163a329.

PMID:
18665072
17.

Combining differential expression, chromosomal and pathway analyses for the molecular characterization of renal cell carcinoma.

Furge KA, Dykema K, Petillo D, Westphal M, Zhang Z, Kort EJ, Teh BT.

Can Urol Assoc J. 2007 Jun;1(2 Suppl):S21-7.

18.

The E2F3-Oncomir-1 axis is activated in Wilms' tumor.

Kort EJ, Farber L, Tretiakova M, Petillo D, Furge KA, Yang XJ, Cornelius A, Teh BT.

Cancer Res. 2008 Jun 1;68(11):4034-8. doi: 10.1158/0008-5472.CAN-08-0592.

19.

Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization.

Yang XJ, Zhou M, Hes O, Shen S, Li R, Lopez J, Shah RB, Yang Y, Chuang ST, Lin F, Tretiakova MM, Kort EJ, Teh BT.

Am J Surg Pathol. 2008 Feb;32(2):177-87. doi: 10.1097/PAS.0b013e318150df1d.

PMID:
18223319
20.

Anthrax lethal toxin inhibits growth of and vascular endothelial growth factor release from endothelial cells expressing the human herpes virus 8 viral G protein coupled receptor.

Depeille P, Young JJ, Boguslawski EA, Berghuis BD, Kort EJ, Resau JH, Frankel AE, Duesbery NS.

Clin Cancer Res. 2007 Oct 1;13(19):5926-34.

22.

Gene expression profiling in kidney cancer: combining differential expression and chromosomal and pathway analyses.

Furge KA, Kort EJ, Yang XJ, Stadler WM, Kim H, Teh BT.

Clin Genitourin Cancer. 2006 Dec;5(3):227-31.

PMID:
17239277
23.

Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications.

Yao X, Qian CN, Zhang ZF, Tan MH, Kort EJ, Yang XJ, Resau JH, Teh BT.

Clin Cancer Res. 2007 Jan 1;13(1):161-9.

24.

Preparing the "soil": the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells.

Qian CN, Berghuis B, Tsarfaty G, Bruch M, Kort EJ, Ditlev J, Tsarfaty I, Hudson E, Jackson DG, Petillo D, Chen J, Resau JH, Teh BT.

Cancer Res. 2006 Nov 1;66(21):10365-76. Epub 2006 Oct 23.

25.

Requirement of the enzymatic and signaling activities of plasmin for phorbol-ester-induced scattering of colon cancer cells.

Díaz VM, Hurtado M, Kort EJ, Resnati M, Blasi F, Thomson T, Paciucci R.

Exp Cell Res. 2006 Jul 15;312(12):2203-13. Epub 2006 Apr 21.

PMID:
16631161
26.

A molecular classification of papillary renal cell carcinoma.

Yang XJ, Tan MH, Kim HL, Ditlev JA, Betten MW, Png CE, Kort EJ, Futami K, Furge KA, Takahashi M, Kanayama HO, Tan PH, Teh BS, Luan C, Wang K, Pins M, Tretiakova M, Anema J, Kahnoski R, Nicol T, Stadler W, Vogelzang NG, Amato R, Seligson D, Figlin R, Belldegrun A, Rogers CG, Teh BT.

Cancer Res. 2005 Jul 1;65(13):5628-37.

27.

Gene expression profiling of mesoblastic nephroma and Wilms tumors--comparison and clinical implications.

Sugimura J, Yang XJ, Tretiakova MS, Takahashi M, Kort EJ, Fulton B, Fujioka T, Vogelzang NJ, Teh BT.

Urology. 2004 Aug;64(2):362-8; discussion 368.

PMID:
15302496
28.

Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles.

Furge KA, Lucas KA, Takahashi M, Sugimura J, Kort EJ, Kanayama HO, Kagawa S, Hoekstra P, Curry J, Yang XJ, Teh BT.

Cancer Res. 2004 Jun 15;64(12):4117-21.

29.

Gene expression profiling of early- and late-relapse nonseminomatous germ cell tumor and primitive neuroectodermal tumor of the testis.

Sugimura J, Foster RS, Cummings OW, Kort EJ, Takahashi M, Lavery TT, Furge KA, Einhorn LH, Teh BT.

Clin Cancer Res. 2004 Apr 1;10(7):2368-78.

30.

Quantifying cell scattering: the blob algorithm revisited.

Kort EJ, Jones A, Daumbach M, Hudson EA, Buckner B, Resau JH.

Cytometry A. 2003 Feb;51(2):119-26.

31.

A human tissue and data resource: an overview of opportunities, challenges, and development of a provider/researcher partnership model.

Kort EJ, Campbell B, Resau JH.

Comput Methods Programs Biomed. 2003 Feb;70(2):137-50. Review.

PMID:
12507790
32.

Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma.

Qian CN, Guo X, Cao B, Kort EJ, Lee CC, Chen J, Wang LM, Mai WY, Min HQ, Hong MH, Vande Woude GF, Resau JH, Teh BT.

Cancer Res. 2002 Jan 15;62(2):589-96.

33.

Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models.

Cao B, Su Y, Oskarsson M, Zhao P, Kort EJ, Fisher RJ, Wang LM, Vande Woude GF.

Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7443-8.

34.

Predictors of vaccination rates during a mass meningococcal vaccination program on a college campus.

Paneth N, Kort EJ, Jurczak D, Havlichek DA Jr, Braunlich K, Moorer G, Vanderjagt D, Sienko D, Leiby P, Gibbons C.

J Am Coll Health. 2000 Jul;49(1):7-11.

PMID:
10967878
35.

A quantitative analysis of the development of the pyramidal tract in the cervical spinal cord in the rat.

Gorgels TG, De Kort EJ, Van Aanholt HT, Nieuwenhuys R.

Anat Embryol (Berl). 1989;179(4):377-85.

PMID:
2735531
36.

Immunocytochemical distribution of the protein kinase C substrate B-50 (GAP43) in developing rat pyramidal tract.

Gorgels TG, Oestreicher AB, de Kort EJ, Gispen WH.

Neurosci Lett. 1987 Dec 16;83(1-2):59-64.

PMID:
3441300
37.

On the development of the pyramidal tract in the rat. II. An anterograde tracer study of the outgrowth of the corticospinal fibers.

Gribnau AA, de Kort EJ, Dederen PJ, Nieuwenhuys R.

Anat Embryol (Berl). 1986;175(1):101-10.

PMID:
3799984
38.

On the development of the pyramidal tract in the rat. I. The morphology of the growth zone.

de Kort EJ, Gribnau AA, van Aanholt HT, Nieuwenhuys R.

Anat Embryol (Berl). 1985;172(2):195-204.

PMID:
4051195
39.
40.

On the development of the spinal cord of the clawed frog, Xenopus laevis. I. Morphogenesis and histogenesis.

Thors F, de Kort EJ, Nieuwenhuys R.

Anat Embryol (Berl). 1982;164(3):427-41.

PMID:
7137589

Supplemental Content

Support Center